UK tribunal upholds CMA pharma collusion fine
The UK’s Competition Appeal Tribunal has confirmed the Competition and Markets Authority’s finding that Lexon colluded with rival drug suppliers to keep up prices of an antidepressant sold to the National Health Service.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10